| Financial Year |
March 31 2023 |
| Monetary Funds |
896,390,780.89 |
| Held-for-trading Financial Assets |
3,144,400,684.93 |
| Notes Receivable |
2,752,347.81 |
| Accounts Receivable |
788,191,166.12 |
| Advances to Suppliers |
205,925,980.39 |
| Other Receivables |
78,720,818.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,655,402,198.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,006,992,802.78 |
| Other Current Assets |
44,831,213.76 |
| Total Current Assets |
8,824,970,836.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,344,962.52 |
| Investment Properties |
598,265,068.72 |
| Fixed Assetes |
803,822,277.08 |
| Under-construction Projects |
124,700,844.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
951,031,985.91 |
| R&D expenses |
29,759,442.85 |
| Goodwill |
14,773,762.51 |
| Long-Term Deferred and Prepaid Expenses |
57,621,004.21 |
| Deferred Income Tax Assets |
83,782,748.11 |
| Other Non-Current Assets |
1,271,745,621.83 |
| Sub-Total of Non-Current Assets |
5,724,456,483.44 |
| Total Assets |
14,549,427,320.43 |
| Short-Term Loans |
5,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,997,283,232.81 |
| Accounts Received In Advance |
36,612,822.13 |
| Employee Compensation Payable |
215,355,043.43 |
| Taxes Payable |
49,133,851.59 |
| Interest Payable |
140,000.00 |
| Dividend Payable |
1,830,365.67 |
| Other payables |
651,303,476.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
412,899,206.63 |
| Other Current Liabilities |
35,418,543.08 |
| Sub-Total of Current Liabilities |
4,198,465,090.76 |
| Long-term Loans |
16,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,776,457.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,437,475.67 |
| Deferred Income Tax Liabilities |
19,306,216.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,107,393,127.18 |
| Total Liabilities |
5,305,858,217.94 |
| Paid-In Capital(Or Share Stock) |
1,822,500,000.00 |
| Capital Surplus |
1,138,096,904.44 |
| Surplus Reserve |
196,775,633.25 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,125,266,958.72 |
| Minority Stockholder's Interest |
1,037,964,414.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,205,604,687.88 |
| Owner's Equity（Stockholder's Equity） |
9,243,569,102.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,549,427,320.43 |
